SEC Form 4 · accession 0001140361-17-032693
Westlake Chemical Partners LP · WLKP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Max L Lukens
Director
Period of report
Aug 16, 2017
Accepted (ET)
Aug 18, 2017 · 3:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604665
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom UnitsF1 | — | Aug 16, 2017 | A | 3,382 | A | Aug 16, 2018 | Sep 15, 2018 | Common Units | 3,382 | 3,382 | D |
Explanation of responses
- F1Each Phantom Unit is the economic equivalent of one Common Unit of Issuer.
Remarks
Mr. Lukens is a Director of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP.